aiqbench analysis
This study benchmarks classical machine learning algorithms on multi-omics data to predict Estrogen Receptor status in breast cancer, demonstrating that Random Forest outperforms other models with a balanced accuracy of 90.3%. The research confirms that while RNA expression provides the strongest signal, integrating genomic and proteomic modalities offers consistent improvements for small, high-dimensional datasets without requiring deep learning architectures.
Benchmarking Machine Learning Models for Multi-Omics-Based Breast Cancer Prediction
arXiv:2607.16250v1 Announce Type: cross Abstract: Estrogen Receptor (ER) status is a critical biomarker in breast cancer diagnosis, prognosis, and treatment selection. Recent advances in high-throughput sequencing technologies have enabled the generation of multi-omics datasets that provide complementary molecular information for computational prediction tasks. This study presents a systematic benchmarking analysis of classical machine learning models for ER status prediction using transcriptomic (RNA expression), genomic (copy number variation; CNV), and proteomic (RPPA) data from the TCGA-BRCA cohort. A rigorous experimental framework incorporating stratified train-test splitting, stratified five-fold cross-validation, class imbalance handling, and fold-specific feature selection was employed to ensure reliable evaluation and prevent data leakage. Random Forest, XGBoost, LightGBM, CatBoost, Support Vector Machines (SVM), and Logistic Regression were evaluated across single-omic and multi-omic settings. Results demonstrated that RNA expression provided the strongest predictive signal, while multi-omic integration yielded modest but consistent improvements over individual modalities. Among all evaluated approaches, Random Forest achieved the best overall performance in the integrated multi-omic setting, obtaining a balanced accuracy of 90.3\% and an ROC-AUC of 97.1\%. Furthermore, recurrent selection of biologically relevant genes, including \textit{ESR1}, \textit{PGR}, \textit{FOXA1}, and \textit{GATA3}, supported the biological validity of the learned models. These findings indicate that carefully regularized classical machine learning methods remain highly effective for small, high-dimensional genomic datasets and that multi-omic integration provides complementary information for breast cancer ER status prediction.
Abstract:Estrogen Receptor (ER) status is a critical biomarker in breast cancer diagnosis, prognosis, and treatment selection. Recent advances in high-throughput sequencing technologies have enabled the generation of multi-omics datasets that provide complementary molecular information for computational prediction tasks. This study presents a systematic benchmarking analysis of classical machine learning models for ER status prediction using transcriptomic (RNA expression), genomic (copy number variation; CNV), and proteomic (RPPA) data from the TCGA-BRCA cohort. A rigorous experimental framework incorporating stratified train-test splitting, stratified five-fold cross-validation, class imbalance handling, and fold-specific feature selection was employed to ensure reliable evaluation and prevent data leakage. Random Forest, XGBoost, LightGBM, CatBoost, Support Vector Machines (SVM), and Logistic Regression were evaluated across single-omic and multi-omic settings. Results demonstrated that RNA expression provided the strongest predictive signal, while multi-omic integration yielded modest but consistent improvements over individual modalities. Among all evaluated approaches, Random Forest achieved the best overall performance in the integrated multi-omic setting, obtaining a balanced accuracy of 90.3\% and an ROC-AUC of 97.1\%. Furthermore, recurrent selection of biologically relevant genes, including \textit{ESR1}, \textit{PGR}, \textit{FOXA1}, and \textit{GATA3}, supported the biological validity of the learned models. These findings indicate that carefully regularized classical machine learning methods remain highly effective for small, high-dimensional genomic datasets and that multi-omic integration provides complementary information for breast cancer ER status prediction.
Machine Learning (cs.LG); Artificial Intelligence (cs.AI)
arXiv:2607.16250 [cs.LG]
(or arXiv:2607.16250v1 [cs.LG] for this version)
https://doi.org/10.48550/arXiv.2607.16250 Focus to learn more arXiv-issued DOI via DataCite
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 313 words
Related coverage
Multi-Modal Machine Learning for Breast Cancer Recurrence Prediction
arXiv · Jun 3, 2026
Beyond SBDD: Geometric Deep Learning in Polypharmacology and Multi-target Drug Design
arXiv · Jul 24, 2026

Research Note: Filtering Subversion-Relevant Information From Pretraining Data Is Feasible
LessWrong · Oct 5, 2026
Tool-Augmented On-Policy Distillation for LLM Domain Adaptation in Sequence-Based Omics Tasks
arXiv · Sep 22, 2026